Literature DB >> 18430857

Potential role of diffusion tensor MRI in the differential diagnosis of mild cognitive impairment and Alzheimer's disease.

Daniella B Parente1, Emerson L Gasparetto, Luiz Celso Hygino da Cruz, Roberto Cortes Domingues, Ana Célia Baptista, Antônio Carlos Pires Carvalho, Romeu Cortes Domingues.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the fractional anisotropy values of several white matter tracts with the aim of differentiating a healthy population from persons with mild cognitive impairment or Alzheimer's disease. SUBJECTS AND METHODS: Seventy-nine patients with memory impairment and 16 volunteer controls participated in the study. MRI was performed with a 1.5-T system. Conventional MR images and diffusion tensor images were obtained for all participants. The diffusion tensor imaging data were postprocessed, and low b-value, fractional anisotropy, and fractional anisotropy color-coded maps were calculated. With the three maps as an anatomic reference, fractional anisotropy was measured for hippocampal formations, superior longitudinal fascicles, posterior cingulate gyri, and the splenium of the corpus callosum. Kruskal-Wallis and Steel-type multiple-comparison nonparametric tests were performed for the statistical analysis.
RESULTS: The fractional anisotropy values for the splenium of the corpus callosum, bilateral posterior cingulate gyri, and bilateral superior longitudinal fascicles of patients with mild cognitive impairment and those with probable Alzheimer's disease were significantly lower than the values of controls. No differences were found in hippocampal formations in any group. No significant difference was found in fractional anisotropy values in comparisons of mild cognitive impairment versus possible Alzheimer's disease and probable Alzheimer's disease or comparisons of probable Alzheimer's disease and possible Alzheimer's disease.
CONCLUSION: Diffusion tensor imaging is a promising technique for the evaluation of patients with probable mild cognitive impairment. Early detection of the disease expands the treatment options, increasing the likelihood of a good clinical response and enhancing the quality of life of patients and their relatives. Further studies with larger populations are needed to confirm the role of diffusion tensor imaging in the evaluation of memory impairment.

Entities:  

Mesh:

Year:  2008        PMID: 18430857     DOI: 10.2214/AJR.07.2617

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  28 in total

1.  Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients.

Authors:  Sabine Deprez; Frederic Amant; Refika Yigit; Kathleen Porke; Judith Verhoeven; Jan Van den Stock; Ann Smeets; Marie-Rose Christiaens; Alexander Leemans; Wim Van Hecke; Joris Vandenberghe; Mathieu Vandenbulcke; Stefan Sunaert
Journal:  Hum Brain Mapp       Date:  2011-03       Impact factor: 5.038

2.  Decreased white matter integrity in neuropsychologically defined mild cognitive impairment is independent of cortical thinning.

Authors:  Nikki H Stricker; David H Salat; Jessica M Foley; Tyler A Zink; Ida L Kellison; Craig P McFarland; Laura J Grande; Regina E McGlinchey; William P Milberg; Elizabeth C Leritz
Journal:  J Int Neuropsychol Soc       Date:  2013-07-01       Impact factor: 2.892

3.  Mild Cognitive Impairment is Associated With White Matter Integrity Changes in Late-Myelinating Regions Within the Corpus Callosum.

Authors:  Nikki H Stricker; David H Salat; Taylor P Kuhn; Jessica M Foley; Jenessa S Price; Lars T Westlye; Michael S Esterman; Regina E McGlinchey; William P Milberg; Elizabeth C Leritz
Journal:  Am J Alzheimers Dis Other Demen       Date:  2015-04-22       Impact factor: 2.035

4.  Longitudinal changes of fractional anisotropy in Alzheimer's disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study.

Authors:  Y Likitjaroen; T Meindl; U Friese; M Wagner; K Buerger; H Hampel; S J Teipel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-08-05       Impact factor: 5.270

5.  Diffusion Tensor Imaging in Preclinical Huntington's Disease.

Authors:  Vincent A Magnotta; Jinsuh Kim; Tim Koscik; Leigh J Beglinger; Daisy Espinso; Doug Langbehn; Peg Nopoulos; Jane S Paulsen
Journal:  Brain Imaging Behav       Date:  2009-03-01       Impact factor: 3.978

6.  Differences in microstructural alterations of the hippocampus in Alzheimer disease and idiopathic normal pressure hydrocephalus: a diffusion tensor imaging study.

Authors:  Y J Hong; B Yoon; Y S Shim; A H Cho; S C Lim; K J Ahn; D W Yang
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-29       Impact factor: 3.825

7.  Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology.

Authors:  Maya K Desai; Kelly L Sudol; Michelle C Janelsins; Michael A Mastrangelo; Maria E Frazer; William J Bowers
Journal:  Glia       Date:  2009-01-01       Impact factor: 7.452

8.  Serum cholesterol and variant in cholesterol-related gene CETP predict white matter microstructure.

Authors:  Nicholus M Warstadt; Emily L Dennis; Neda Jahanshad; Omid Kohannim; Talia M Nir; Katie L McMahon; Greig I de Zubicaray; Grant W Montgomery; Anjali K Henders; Nicholas G Martin; John B Whitfield; Clifford R Jack; Matt A Bernstein; Michael W Weiner; Arthur W Toga; Margaret J Wright; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2014-06-02       Impact factor: 4.673

9.  Different patterns of white matter disruption among amnestic mild cognitive impairment subtypes: relationship with neuropsychological performance.

Authors:  He Li; Ying Liang; Kewei Chen; Xin Li; Ni Shu; Zhanjun Zhang; Yongyan Wang
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI.

Authors:  Yu Zhang; Norbert Schuff; An-Tao Du; Howard J Rosen; Joel H Kramer; Maria Luisa Gorno-Tempini; Bruce L Miller; Michael W Weiner
Journal:  Brain       Date:  2009-05-12       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.